Expression of E-cadherin in squamous cell carcinomas of the cervix with correlations to clinicopathological features
dc.contributor.author | Yaldiz, M | |
dc.contributor.author | Hakverdi, AU | |
dc.contributor.author | Bayhan, G | |
dc.contributor.author | Akkus, Z | |
dc.date.accessioned | 2024-04-24T17:33:55Z | |
dc.date.available | 2024-04-24T17:33:55Z | |
dc.date.issued | 2005 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description.abstract | Objective: To evaluate the expression of E-cadherin, a calcium-dependent cell adhesion molecule, in a retrospective analysis of paraffin-embedded tissue specimens of cervical squamous carcinoma and the relationship with histopathological differentiation and lymph node status. Methods: In this study, we investigated by immunohistochemistry E-cadherin expression in ten normal cervical epithelia and 24 cervical invasive squamous carcinomas. Results: Normal cervical squamous epithelium showed strong expression of E-cadherin at the membrane of the cell and intercellular junctions. In 24 tumors immunnostained by E-cadherin antibody, 11 (46%) showed preserved expression and 13 (54%) reduced expression. There was no significant correlation between E-cadherin expression and histological differentiation (p = 0.650, p = 0.294). In the status of lymph node metastasis, reduced expression of E-cadherin was seen in 11/15 (73%) with lymph node metastasis versus 2/9 (22%) without lymph node metastasis. There was a significant inverse correlation between E-cadherin expression and lymph node metastasis (p = 0.032). Conclusion: Reduced E-cadherin expression may be an important factor among a variety of biologic events that occur during the process of metastasis. However, this should be explored by a large scale study. | en_US |
dc.identifier.endpage | 98 | en_US |
dc.identifier.issn | 0392-2936 | |
dc.identifier.issue | 1 | en_US |
dc.identifier.pmid | 15755011 | |
dc.identifier.scopus | 2-s2.0-14644411009 | |
dc.identifier.scopusquality | N/A | |
dc.identifier.startpage | 95 | en_US |
dc.identifier.uri | https://hdl.handle.net/11468/20890 | |
dc.identifier.volume | 26 | en_US |
dc.identifier.wos | WOS:000227340800019 | |
dc.identifier.wosquality | Q4 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | en_US |
dc.publisher | I R O G Canada, Inc | en_US |
dc.relation.ispartof | European Journal of Gynaecological Oncology | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Cervix | en_US |
dc.subject | Squamous Cell Carcinoma | en_US |
dc.subject | E-Cadherin | en_US |
dc.title | Expression of E-cadherin in squamous cell carcinomas of the cervix with correlations to clinicopathological features | en_US |
dc.title | Expression of E-cadherin in squamous cell carcinomas of the cervix with correlations to clinicopathological features | |
dc.type | Article | en_US |